Integra Lifesciences (NASDAQ: IART) and Landauer (NYSE:LDR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, valuation, analyst recommendations, risk and institutional ownership.
This table compares Integra Lifesciences and Landauer’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of current recommendations and price targets for Integra Lifesciences and Landauer, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Integra Lifesciences currently has a consensus target price of $51.88, suggesting a potential downside of 3.02%. Given Integra Lifesciences’ stronger consensus rating and higher probable upside, research analysts clearly believe Integra Lifesciences is more favorable than Landauer.
Earnings & Valuation
This table compares Integra Lifesciences and Landauer’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Integra Lifesciences||$992.08 million||4.23||$74.56 million||$0.61||87.69|
Integra Lifesciences has higher revenue and earnings than Landauer. Landauer is trading at a lower price-to-earnings ratio than Integra Lifesciences, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Integra Lifesciences has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, Landauer has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.
Insider and Institutional Ownership
87.6% of Integra Lifesciences shares are held by institutional investors. Comparatively, 79.6% of Landauer shares are held by institutional investors. 21.5% of Integra Lifesciences shares are held by company insiders. Comparatively, 6.6% of Landauer shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Landauer pays an annual dividend of $1.10 per share and has a dividend yield of 1.6%. Integra Lifesciences does not pay a dividend. Landauer pays out 57.3% of its earnings in the form of a dividend.
Integra Lifesciences beats Landauer on 8 of the 14 factors compared between the two stocks.
About Integra Lifesciences
Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.
Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries. Medical physics services are provided through the Company’s Landauer Medical Physics (LMP) division. The Company uses LMP as a platform to expand into the medical physics services market, serving domestic hospitals, radiation therapy centers and imaging centers. The Company’s Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures.
Receive News & Ratings for Integra Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.